Src family tyrosine kinases participate in insulin-like growth factor I mitogenic signaling in 3T3-L1 cells

Cell Growth and Differentiation

Volumn 12, Issue 7, 2001, Pages 379-386

  Boney, C M ^a   Sekimoto, H ^a   Gruppuso, P A ^a   Frackelton A R , Jr ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGENIC AGENT; PROTEIN KINASE FYN; PROTEIN TYROSINE KINASE; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN 3T3; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVATION; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION;

3T3 CELLS; ANIMALS; CELL DIVISION; DNA; ENZYME INHIBITORS; IMMUNOBLOTTING; INSULIN-LIKE GROWTH FACTOR I; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEINS; PRECIPITIN TESTS; PYRAZOLES; PYRIMIDINES; SRC-FAMILY KINASES; VIRULENCE FACTORS, BORDETELLA;

EID: 0034917948     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Mice carrying null mutations of the genes encoding insulin-like growth factor-I and type I IGF receptor
2. Growth, differentiation, and survival: Multiple physiological functions for insulin-like growth factors
3. Inhibition of IGF-I mitogenic action by zinc chelation is associated with a decreased mitogen-activated protein kinase activation in RAT-1 fibroblasts
4. Proadipocyte cell lines: Models of cellular proliferation and differentiation
5. Molecular and cellular aspects of the insulin-like growth factor-I receptor
6. How MAP kinases are regulated
7. The insulin signaling system and the IRS proteins
8. The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes
9. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells
10. Insulin-receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover
11. Phosphatidylinositol 3-kinase is required for insulin-like growth factor-I-induced vascular smooth muscle cell proliferation and migration
12. Insulin receptor substrate-2 and Shc play different roles in insulin-like growth factor-I signaling
13. IGF-I synergizes with interleukin-4 for hematopoietic cell proliferation independent of insulin receptor substrate expression
14. The dominant negative effect of a kinase-defective insulin receptor on IGF-I-stimulated signaling in Rat-1 fibroblasts
15. Modulation of insulin-like growth factor-I mitogenic signaling in 3T3-L1 preadipocyte differentiation
16. Insulin-like growth factor-I receptor internalization regulates signaling via the Shc/mitogen-activated protein kinase pathway, but not the insulin receptor substrate-1 pathway
17. Transactivation of the EGF receptor mediates IGF-I stimulated Shc phosphorylation and ERK1/2 activation in COS-7 cells
18. Src phosphorylates the insulin-like growth factor type 1 receptor on the autophosphorylation sites. Requirement for transformation by src
19. Src family tyrosine kinases and growth factor signaling
20. DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases
21. Src stimulates insulin-like growth factor-I-dependent cell proliferation by increasing IGF-I receptor number in human pancreatic carcinoma cells
22. Insulin-like growth factor-I receptor signaling in transformation by src oncogenes
23. C-terminal Src kinase associates with ligand-stimulated insulin-like growth factor-I receptor
24. Potentiation of neuronal L calcium channels by IGF-I requires phosphorylation of the α1 subunit on a specific tyrosine residue
25. Discovery of a novel, potent and Src family-selective tyrosine kinase inhibitor
26. Structural basis for selective inhibition of Src family kinases by PP1
27. A target for Src in mitosis
28. Requirement for c-Src catalytic activity and the SH3 domain in platelet-derived growth factor BB and epidermal growth factor mitogenic signaling
29. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions
30. Evidence for the direct interaction of the insulin-like growth factor-I receptor with IRS-1, Shc and Grb10
31. Src promotes PCKδ degradation
32. The Fyn tyrosine kinase binds IRS-1 and forms a distinct signaling complex during insulin stimulation
33. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation
34. Activation of Src-family protein tyrosine kinases and phosphatidylinositol 3-kinase in 3T3-L1 mouse preadipocytes by interleukin-11
35. Inhibition of Src kinases by a selective tyrosine kinase inhibitor causes mitotic arrest
36. Knock-outs of Src-family kinases: Stiff bones, wimpy T cells and bad memories
37. Characterization of cDNA clones for the human c-yes gene
38. Intracellular transactivation of the IGF-I receptor by an epidermal growth factor receptor
39. Gβγ subunits mediate mitogen-activated protein kinase activation by the tyrosine kinase insulin-like growth factor-I receptor
40. Association of heterotrimeric Gwith the insulin-like growth factor receptor
41. Pertussis toxin-sensitive and insensitive intracellular signaling pathways in undifferentiated 3T3-L1 cells stimulated by insulin converge with phosphatidylinositol 3-kinase upstream of Ras mitogen-activated protein kinase cascade
42. Src tyrosine kinase is a novel direct effector of G proteins
43. s protein α-subunit sequence accelerate differentiation of fibroblasts to adipocytes
44. Combined deficiencies of Src, Fyn and Yes tyrosine kinases in mutant mice
45. Activation and translocation of c-Src to the cytoskeleton by both platelet-derived growth factor and epidermal growth factor
46. Selected glimpses into the activation and function of Src kinase
47. Src family protein tyrosine kinases: Cooperating with growth factor and adhesion signaling pathways
48. Mitogenic signaling via G protein-coupled receptors
49. β-arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the IGF-I receptor
50. β-arrestin-dependent formation of β2 adrenergic receptor-Src protein kinase complexes
51. β-arrestin1 interacts with the catalytic domain of the tyrosine kinase c-Src. Role of β-arrestin1-dependent targeting of c-Src in receptor endocytosis
52. Detection of Src homology 3-binding proteins, including paxillin, in normal and v-Src-transformed Balb/c3T3 cells